Therapeutic effect of cabazitaxel and blood-brain barrier opening in a patient-derived glioblastoma model

Client

• Regional Health Authority / 900000
• Liaison Committee between the Central Norway Regional health Authority (RHA) and the Norwegian University of Science and Technology (NTNU) / 90270600
• Research Council of Norway (RCN) / 240316

Author(s)

• Einar Sulheim
• Ýrr Asbjørg Mørch
• Sofie Snipstad
• Sven Even Borgos
• Hrvoje Miletic
• Rolf Bjerkvig
• Catharina de Lange Davies
• Andreas Åslund

Affiliation

• Norwegian University of Science and Technology
• St. Olavs Hospital, Trondheim University Hospital
• SINTEF Industry / Biotechnology and Nanomedicine
• University of Bergen
• Bergen Hospital Trust - Haukeland University Hospital
• Luxembourg Institute of Health

Issue

1

DOI

Read fulltext